Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event rates to placebo in Phase 3 ICONIC-ADVANCE studies.1 Icotrokinra also showed ...

Sotatercept, an activin-signaling inhibitor, reduces morbidity and mortality among patients with long-standing pulmonary arterial hypertension. Its effects in patients with pulmonary arterial ...

Can yoga work if you can’t stand? Yes, chair yoga helps seniors build strength, balance, reduce pain, and improve mood.

A major climate change report has laid out a dire future. Meanwhile Minister Murray Watt has handed another win to Woodside.

Genmab acquires Merus for $8bn, adding promising oncology asset petosemtamab. Check out my thoughts on this deal and my ratings on GMAB and MRUS stocks.

Experts stress cautious, evidence-driven use of cannabis in medical practice, highlighting potential benefits, risks, and need for further research.

Falcon Oil & Gas Ltd. Tamboran to acquire Falcon Oil & Gas Ltd. to create ~2.9-million-acre Beetaloo Basin business 30 September ...

Health systems, lawmakers and primary care providers are answering a call coming from women to provide more menopause care. Every year, 1.3 million American women reach menopause, which has an average ...

Discover Immuneering’s latest breakthrough: atebimetinib delivers unprecedented survival rates in first-line pancreatic cancer.

Novocure (NASDAQ: NVCR) announced that final results from the Phase 3 METIS trial of Tumor Treating Fields (TTFields) therapy for brain metastases from non-small cell lung cancer (NSCLC) will be ...

Phase 2 randomized, double-blind, placebo-controlled trial planned to evaluate TNX-2900 in children and adolescents (ages 8 to 17.5 years) with ...

CAN-2409 improved disease-free survival in patients with intermediate-to-high-risk, localized prostate cancer compared to placebo in patients treated with either conventional or moderate ...